6989 Novel Use of Dual GIP/GLP-1 Receptor Agonist in HNF4A-MODY
Sign Up to like & getrecommendations! Published in 2024 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvae163.869
Abstract: Abstract Disclosure: A. Mehdi: None. M.C. Foss de Freitas: Advisory Board Member; Self; PTC Pharmaceuticals. Other; Self; Scientific presenter in a symposium funded by Amryt Pharmaceuticals. C.L. Martin: None. B.E. Gregg: None. N. Nachawi: None.… read more here.
Keywords: hnf4a mody; mody; gip glp; receptor ... See more keywords
1228-P: Pregnancy Outcomes in Women with HNF4A and HNF1A-MODY
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes"
DOI: 10.2337/db24-1228-p
Abstract: Introduction & Objective: HNF4A-MODY is associated with macrosomia and neonatal hypoglycemia. Glycemic control is achieved during pregnancy with insulin or sulphonylurea therapy. We aim to determine pregnancy outcomes in women with HNF4A-MODY and HNF1A-MODY. Methods:… read more here.
Keywords: hnf4a mody; mody; hnf1a mody; pregnancy outcomes ... See more keywords